Core Viewpoint - Metropolitan Bank Holding Corp. (MCB) is positioned as a strong investment opportunity due to its improving earnings outlook and analysts' increasing earnings estimates [1][2]. Earnings Estimates - Analysts have raised their earnings estimates for Metropolitan Bank Holding, which is expected to positively influence the stock price [2]. - The current-quarter earnings estimate is $2.35 per share, reflecting a +62.1% change from the previous year [6]. - The consensus estimate for the current quarter has increased by 8.29% over the last 30 days, with one estimate going higher and no negative revisions [6]. - For the full year, the earnings estimate stands at $9.99 per share, indicating a +50.9% change from the year-ago figure [7]. Estimate Revisions Trend - The trend for current-year estimate revisions is positive, with one estimate moving higher and no negative revisions, leading to a 6.96% increase in the consensus estimate [8]. - The strong agreement among analysts in raising estimates supports the positive outlook for the company [3]. Zacks Rank - Metropolitan Bank Holding has achieved a Zacks Rank 1 (Strong Buy), indicating favorable estimate revisions and a strong potential for stock performance [9]. - Stocks with Zacks Rank 1 and 2 have historically outperformed the S&P 500 [9]. Stock Performance - The stock has gained 15.8% over the past four weeks, reflecting investor confidence driven by solid estimate revisions [10].

Banco Bilbao (BBVA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.The power o ...

Core Viewpoint - DBS Group Holdings Ltd has been upgraded to a Zacks Rank 2 (Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system reflects changes in earnings estimates, which are strongly correlated with near-term stock price movements, particularly due to institutional investors adjusting their valuations based on these estimates [4][6]. - An increase in earnings estimates typically leads to higher fair value for a stock, prompting institutional investors to buy or sell, thus affecting stock prices [4]. Business Outlook - The upgrade in rating for DBS Group suggests an improvement in the company's underlying business, which should encourage investors to drive the stock price higher [5]. - The Zacks Consensus Estimate for DBS Group indicates expected earnings of $12.34 per share for the fiscal year ending December 2026, with a 4.1% increase in estimates over the past three months [8]. Zacks Rating System - The Zacks Rank system categorizes stocks into five groups based on earnings estimates, with a proven track record of Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [7]. - Only the top 20% of Zacks-covered stocks receive a "Strong Buy" or "Buy" rating, with the upgrade of DBS Group positioning it in this top tier, suggesting potential for market-beating returns [9][10].

Core Viewpoint - CareTrust REIT (CTRE) has been upgraded to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system is based solely on a company's changing earnings picture, which is tracked through the Zacks Consensus Estimate for EPS from sell-side analysts [1][2]. - Changes in future earnings potential, as indicated by earnings estimate revisions, are strongly correlated with near-term stock price movements [4][6]. CareTrust REIT's Earnings Outlook - The recent upgrade for CareTrust REIT reflects a positive outlook on its earnings, suggesting potential buying pressure and an increase in stock price [3][5]. - Analysts have raised their earnings estimates for CareTrust REIT, with the Zacks Consensus Estimate for the fiscal year ending December 2025 projected at $1.77 per share, showing a 0.7% increase over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have generated an average annual return of +25% since 1988 [7]. - CareTrust REIT's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].

Core Viewpoint - Guess (GES) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook for the company's earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system is based on changes in earnings estimates, which are crucial for predicting near-term stock price movements [2][4]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in buying or selling pressure that affects stock prices [4]. Business Improvement Indicators - The upgrade reflects an improvement in Guess's underlying business, suggesting that investors may respond positively by driving the stock price higher [5]. - The Zacks Consensus Estimate for Guess indicates expected earnings of $1.69 per share for the fiscal year ending January 2026, with a 6% increase in estimates over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Only the top 5% of Zacks-covered stocks receive a "Strong Buy" rating, indicating superior earnings estimate revisions and potential for market-beating returns [9][10].

Core Viewpoint - RB Global (RBA) has received an upgrade to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][2]. Earnings Estimates and Stock Price Movement - The Zacks rating system is effective for individual investors as it focuses on earnings estimate revisions, which are closely correlated with near-term stock price movements [2][3]. - Institutional investors rely on earnings estimates to determine the fair value of stocks, leading to price movements based on their buying or selling actions [3]. Business Improvement Indicators - The increase in earnings estimates and the Zacks rating upgrade for RB Global suggest an improvement in the company's underlying business, which could lead to higher stock prices [4]. Importance of Earnings Estimate Revisions - Research indicates a strong correlation between earnings estimate revisions and stock movements, making it beneficial for investors to track these revisions [5]. - The Zacks Rank system utilizes four factors related to earnings estimates to classify stocks, with a proven track record of performance [6]. Specifics on RB Global's Earnings Estimates - RB Global is projected to earn $3.87 per share for the fiscal year ending December 2025, with no year-over-year change expected [7]. - Over the past three months, the Zacks Consensus Estimate for RB Global has increased by 3.2% [7]. Zacks Rating System Overview - The Zacks rating system maintains a balanced distribution of "buy" and "sell" ratings across its universe of over 4,000 stocks, with only the top 5% receiving a "Strong Buy" rating [8]. - RB Global's upgrade to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating strong potential for market-beating returns [9].

Core Viewpoint - Century Therapeutics, Inc. has been upgraded to a Zacks Rank 1 (Strong Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][4]. Earnings Estimates - The Zacks Consensus Estimate for Century Therapeutics indicates an expected earnings of -$0.14 per share for the fiscal year ending December 2025, showing no year-over-year change [9]. - Over the past three months, the Zacks Consensus Estimate for the company has increased by 31.9%, reflecting a positive outlook on earnings [9]. Zacks Rating System - The Zacks rating system is based solely on a company's changing earnings picture, which is tracked through the consensus of EPS estimates from sell-side analysts [2]. - The system classifies stocks into five groups, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [8]. - Only the top 5% of Zacks-covered stocks receive a "Strong Buy" rating, indicating superior earnings estimate revisions [10][11]. Market Implications - Rising earnings estimates and the subsequent rating upgrade for Century Therapeutics suggest an improvement in the company's underlying business, likely leading to increased stock prices [6]. - The correlation between earnings estimate revisions and near-term stock movements highlights the importance of tracking these revisions for investment decisions [7].

Core Viewpoint - SK Telecom has been upgraded to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system is based on changes in a company's earnings picture, which is crucial for predicting near-term stock price movements [2][4]. - Rising earnings estimates for SK Telecom indicate an improvement in the company's underlying business, likely leading to an increase in stock price [5][8]. Zacks Rating System - The Zacks Rank stock-rating system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have generated an average annual return of +25% since 1988 [7][9]. - The upgrade of SK Telecom to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [10]. Earnings Estimate Revisions - For the fiscal year ending December 2025, SK Telecom is expected to earn $0.56 per share, which remains unchanged from the previous year, but the Zacks Consensus Estimate has increased by 6.3% over the past three months [8].

Core Insights - ACNB reported quarterly earnings of $1.35 per share, exceeding the Zacks Consensus Estimate of $1.26 per share, and showing a significant increase from $0.77 per share a year ago, resulting in an earnings surprise of +6.86% [1] - The company posted revenues of $37.18 million for the quarter ended December 2025, which fell short of the Zacks Consensus Estimate by 7.24%, compared to $26.92 million in the same quarter last year [2] - ACNB has surpassed consensus EPS estimates three times over the last four quarters, indicating a positive trend in earnings performance [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.23 on revenues of $40.19 million, while for the current fiscal year, the estimate is $5.20 on revenues of $164.53 million [7] - The estimate revisions trend for ACNB was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, suggesting expected outperformance in the near future [6] Industry Context - The Banks - Southwest industry, to which ACNB belongs, is currently ranked in the top 29% of over 250 Zacks industries, indicating a favorable industry outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact ACNB's stock performance [5]

Core Viewpoint - UP Fintech Holding Limited (TIGR) shows potential for significant upside, with a mean price target of $13.31 indicating a 46.3% increase from its current price of $9.1 [1] Price Targets - The average price target consists of six estimates ranging from a low of $4.73 to a high of $17.50, with a standard deviation of $4.69, indicating variability among analysts [2] - The lowest estimate suggests a potential decline of 48%, while the highest indicates a possible upside of 92.3% [2] Analyst Sentiment - Analysts are optimistic about TIGR's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlate with stock price movements [4][11] - Over the past 30 days, one earnings estimate has increased, leading to a 30% rise in the Zacks Consensus Estimate for the current year [12] Zacks Rank - TIGR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting strong potential for upside [13] Price Movement Guidance - While the consensus price target may not be a reliable predictor of the extent of TIGR's gains, it does provide a useful indication of the expected direction of price movement [14]